NIOX Group Plc (AIM: NIOX)

Market Cap	283.26M
Revenue (ttm)	36.80M
Net Income (ttm)	10.70M
Shares Out	424.05M
EPS (ttm)	0.02
PE Ratio	31.66
Forward PE	23.89
Dividend	0.01 (1.53%)
Ex-Dividend Date	May 23, 2024

Volume	13,241
Open	66.50
Previous Close	65.40
Day's Range	65.80 - 66.99
52-Week Range	57.20 - 75.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 24, 2024

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2006
• Employees: 92
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: NIOX

Financial Performance

In 2023, NIOX Group's revenue was 36.80 million, an increase of 17.57% compared to the previous year's 31.30 million. Earnings were 10.70 million, a decrease of -33.54%.